In vitro interactions of TNO6 with human plasma

The ability of TNO6 to react with human plasma was investigated by in vitro incubation of plasma or plasma fractions with injectable TNO6. HPLC, ultrafiltration and flameless atomic absorption spectrophotometry were used to separate the platinum-containing chemical species and to measure the platinu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer chemotherapy and pharmacology 1983, Vol.11 (3), p.177-181
Hauptverfasser: HECQUET, B, ADENIS, L, DEMAILLE, A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 181
container_issue 3
container_start_page 177
container_title Cancer chemotherapy and pharmacology
container_volume 11
creator HECQUET, B
ADENIS, L
DEMAILLE, A
description The ability of TNO6 to react with human plasma was investigated by in vitro incubation of plasma or plasma fractions with injectable TNO6. HPLC, ultrafiltration and flameless atomic absorption spectrophotometry were used to separate the platinum-containing chemical species and to measure the platinum content. The initial concentration of TNO6 in plasma declines very rapidly. The kinetics of the loss of initial TNO6 is very different from that of cisplatin loss. Most of the TNO6 is bound more quickly to proteins, while a little is transformed to less reactive or nonreactive platinum species. The level of final nonreactive platinum species depends on the particular plasma concerned. In addition, the reactivity of TNO6 towards proteins is very sensitive to Cl- concentration. The usefulness of HPLC for the study of TNO6 kinetics is demonstrated.
doi_str_mv 10.1007/BF00254200
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80750890</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>80750890</sourcerecordid><originalsourceid>FETCH-LOGICAL-c226t-ff5272f7139ef07f6c24a43ec0a69a5c9c1327506b25b6f71f6f091c5f3bff253</originalsourceid><addsrcrecordid>eNpFkDtPwzAYRS0EKqWwsCN5QAxIoZ_f8QgVhUoVXcocOcZWjfIodgLi3xPUCKY73HPvcBC6JHBHANT8YQlABacAR2hKOKMZ5JwdoykwzjOhgJ-is5TeAYATxiZoImUuhNJTNF81-DN0scWh6Vw0tgttk3Dr8fZlI_FX6HZ419emwfvKpNqcoxNvquQuxpyh1-XjdvGcrTdPq8X9OrOUyi7zXlBFvSJMOw_KS0u54cxZMFIbYbUljCoBsqSilAPnpQdNrPCs9J4KNkM3h999bD96l7qiDsm6qjKNa_tU5DCscw0DeHsAbWxTis4X-xhqE78LAsWvneLfzgBfja99Wbu3P3TUMfTXY2-SNZWPprEh_WGa8cGrZD-eLGlo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>80750890</pqid></control><display><type>article</type><title>In vitro interactions of TNO6 with human plasma</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>HECQUET, B ; ADENIS, L ; DEMAILLE, A</creator><creatorcontrib>HECQUET, B ; ADENIS, L ; DEMAILLE, A</creatorcontrib><description>The ability of TNO6 to react with human plasma was investigated by in vitro incubation of plasma or plasma fractions with injectable TNO6. HPLC, ultrafiltration and flameless atomic absorption spectrophotometry were used to separate the platinum-containing chemical species and to measure the platinum content. The initial concentration of TNO6 in plasma declines very rapidly. The kinetics of the loss of initial TNO6 is very different from that of cisplatin loss. Most of the TNO6 is bound more quickly to proteins, while a little is transformed to less reactive or nonreactive platinum species. The level of final nonreactive platinum species depends on the particular plasma concerned. In addition, the reactivity of TNO6 towards proteins is very sensitive to Cl- concentration. The usefulness of HPLC for the study of TNO6 kinetics is demonstrated.</description><identifier>ISSN: 0344-5704</identifier><identifier>EISSN: 1432-0843</identifier><identifier>DOI: 10.1007/BF00254200</identifier><identifier>PMID: 6685579</identifier><identifier>CODEN: CCPHDZ</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Antineoplastic agents ; Biological and medical sciences ; Chemotherapy ; Cisplatin - metabolism ; Humans ; In Vitro Techniques ; Kinetics ; Medical sciences ; Organoplatinum Compounds - blood ; Organoplatinum Compounds - metabolism ; Pharmacology. Drug treatments ; Plasma - metabolism ; Protein Binding ; Spectrophotometry, Atomic ; Ultrafiltration</subject><ispartof>Cancer chemotherapy and pharmacology, 1983, Vol.11 (3), p.177-181</ispartof><rights>1984 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c226t-ff5272f7139ef07f6c24a43ec0a69a5c9c1327506b25b6f71f6f091c5f3bff253</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=9348436$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6685579$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HECQUET, B</creatorcontrib><creatorcontrib>ADENIS, L</creatorcontrib><creatorcontrib>DEMAILLE, A</creatorcontrib><title>In vitro interactions of TNO6 with human plasma</title><title>Cancer chemotherapy and pharmacology</title><addtitle>Cancer Chemother Pharmacol</addtitle><description>The ability of TNO6 to react with human plasma was investigated by in vitro incubation of plasma or plasma fractions with injectable TNO6. HPLC, ultrafiltration and flameless atomic absorption spectrophotometry were used to separate the platinum-containing chemical species and to measure the platinum content. The initial concentration of TNO6 in plasma declines very rapidly. The kinetics of the loss of initial TNO6 is very different from that of cisplatin loss. Most of the TNO6 is bound more quickly to proteins, while a little is transformed to less reactive or nonreactive platinum species. The level of final nonreactive platinum species depends on the particular plasma concerned. In addition, the reactivity of TNO6 towards proteins is very sensitive to Cl- concentration. The usefulness of HPLC for the study of TNO6 kinetics is demonstrated.</description><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Chemotherapy</subject><subject>Cisplatin - metabolism</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Kinetics</subject><subject>Medical sciences</subject><subject>Organoplatinum Compounds - blood</subject><subject>Organoplatinum Compounds - metabolism</subject><subject>Pharmacology. Drug treatments</subject><subject>Plasma - metabolism</subject><subject>Protein Binding</subject><subject>Spectrophotometry, Atomic</subject><subject>Ultrafiltration</subject><issn>0344-5704</issn><issn>1432-0843</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkDtPwzAYRS0EKqWwsCN5QAxIoZ_f8QgVhUoVXcocOcZWjfIodgLi3xPUCKY73HPvcBC6JHBHANT8YQlABacAR2hKOKMZ5JwdoykwzjOhgJ-is5TeAYATxiZoImUuhNJTNF81-DN0scWh6Vw0tgttk3Dr8fZlI_FX6HZ419emwfvKpNqcoxNvquQuxpyh1-XjdvGcrTdPq8X9OrOUyi7zXlBFvSJMOw_KS0u54cxZMFIbYbUljCoBsqSilAPnpQdNrPCs9J4KNkM3h999bD96l7qiDsm6qjKNa_tU5DCscw0DeHsAbWxTis4X-xhqE78LAsWvneLfzgBfja99Wbu3P3TUMfTXY2-SNZWPprEh_WGa8cGrZD-eLGlo</recordid><startdate>1983</startdate><enddate>1983</enddate><creator>HECQUET, B</creator><creator>ADENIS, L</creator><creator>DEMAILLE, A</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1983</creationdate><title>In vitro interactions of TNO6 with human plasma</title><author>HECQUET, B ; ADENIS, L ; DEMAILLE, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c226t-ff5272f7139ef07f6c24a43ec0a69a5c9c1327506b25b6f71f6f091c5f3bff253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Chemotherapy</topic><topic>Cisplatin - metabolism</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Kinetics</topic><topic>Medical sciences</topic><topic>Organoplatinum Compounds - blood</topic><topic>Organoplatinum Compounds - metabolism</topic><topic>Pharmacology. Drug treatments</topic><topic>Plasma - metabolism</topic><topic>Protein Binding</topic><topic>Spectrophotometry, Atomic</topic><topic>Ultrafiltration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HECQUET, B</creatorcontrib><creatorcontrib>ADENIS, L</creatorcontrib><creatorcontrib>DEMAILLE, A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer chemotherapy and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HECQUET, B</au><au>ADENIS, L</au><au>DEMAILLE, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro interactions of TNO6 with human plasma</atitle><jtitle>Cancer chemotherapy and pharmacology</jtitle><addtitle>Cancer Chemother Pharmacol</addtitle><date>1983</date><risdate>1983</risdate><volume>11</volume><issue>3</issue><spage>177</spage><epage>181</epage><pages>177-181</pages><issn>0344-5704</issn><eissn>1432-0843</eissn><coden>CCPHDZ</coden><abstract>The ability of TNO6 to react with human plasma was investigated by in vitro incubation of plasma or plasma fractions with injectable TNO6. HPLC, ultrafiltration and flameless atomic absorption spectrophotometry were used to separate the platinum-containing chemical species and to measure the platinum content. The initial concentration of TNO6 in plasma declines very rapidly. The kinetics of the loss of initial TNO6 is very different from that of cisplatin loss. Most of the TNO6 is bound more quickly to proteins, while a little is transformed to less reactive or nonreactive platinum species. The level of final nonreactive platinum species depends on the particular plasma concerned. In addition, the reactivity of TNO6 towards proteins is very sensitive to Cl- concentration. The usefulness of HPLC for the study of TNO6 kinetics is demonstrated.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>6685579</pmid><doi>10.1007/BF00254200</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0344-5704
ispartof Cancer chemotherapy and pharmacology, 1983, Vol.11 (3), p.177-181
issn 0344-5704
1432-0843
language eng
recordid cdi_proquest_miscellaneous_80750890
source MEDLINE; SpringerLink Journals
subjects Antineoplastic agents
Biological and medical sciences
Chemotherapy
Cisplatin - metabolism
Humans
In Vitro Techniques
Kinetics
Medical sciences
Organoplatinum Compounds - blood
Organoplatinum Compounds - metabolism
Pharmacology. Drug treatments
Plasma - metabolism
Protein Binding
Spectrophotometry, Atomic
Ultrafiltration
title In vitro interactions of TNO6 with human plasma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T09%3A17%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20interactions%20of%20TNO6%20with%20human%20plasma&rft.jtitle=Cancer%20chemotherapy%20and%20pharmacology&rft.au=HECQUET,%20B&rft.date=1983&rft.volume=11&rft.issue=3&rft.spage=177&rft.epage=181&rft.pages=177-181&rft.issn=0344-5704&rft.eissn=1432-0843&rft.coden=CCPHDZ&rft_id=info:doi/10.1007/BF00254200&rft_dat=%3Cproquest_cross%3E80750890%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=80750890&rft_id=info:pmid/6685579&rfr_iscdi=true